PharmaCyte Biotech Inc (NASDAQ:PMCB)

3.00
Delayed Data
As of Feb 08
 +0.09 / +3.10%
Today’s Change
1.79
Today|||52-Week Range
3.10
+2.39%
Year-to-Date

Stock Price Forecast

There is no forecast data available.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in PharmaCyte Biotech Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
--
Reporting Date
Aug 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually -18.52%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.